Sewoonmedical세운메디칼
100700 · KOSDAQ · ₩100700 · 세운메디칼
₩2,275▼ ₩30 (1.30%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩64B | ₩60B | ₩68B | ₩60B | ₩63B |
| Cost of sales | ₩40B | ₩38B | ₩41B | ₩38B | ₩38B |
| Gross profit | ₩24B | ₩22B | ₩28B | ₩22B | ₩25B |
| Operating income | ₩13B | ₩11B | ₩17B | ₩12B | ₩15B |
| Net income | ₩12B | ₩13B | ₩15B | ₩11B | ₩13B |
| Net income to shareholders | ₩12B | ₩12B | ₩15B | ₩10B | ₩12B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩164B | ₩157B | ₩147B | ₩132B | ₩125B |
| Current assets | ₩129B | ₩119B | ₩108B | ₩92B | ₩83B |
| Cash and equivalents | ₩97B | ₩86B | ₩76B | ₩32B | ₩45B |
| Total liabilities | ₩9.5B | ₩7.8B | ₩8.9B | ₩7.5B | ₩8.8B |
| Current liabilities | ₩8.9B | ₩7B | ₩8.3B | ₩6.7B | ₩8.2B |
| Total equity | ₩154B | ₩149B | ₩138B | ₩125B | ₩116B |
| Shareholders' equity | ₩151B | ₩146B | ₩135B | ₩123B | ₩114B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩18B | ₩13B | ₩23B | ₩9.3B | ₩21B |
| Capital spending | ₩1.7B | ₩1.4B | ₩1.9B | ₩2.2B | ₩2.2B |
| Free cash flow | ₩16B | ₩12B | ₩21B | ₩7.1B | ₩19B |
| Dividends paid | ₩2.6B | ₩3B | ₩2.6B | ₩2.2B | ₩2.2B |
Consolidated where available. Amounts in won.
Also known as: Sewoonmedical / 세운메디칼 / 100700 / KRX:100700
Source: KRX statistical information